Richie Glutathione RCT: Key Findings Explained in Plain Language
Six months of glutathione supplementation increased body GSH stores by 30-35%, with sustained elevation throughout the treatment period.
Study overview
Conducted by
Dr. J.P. Richie et al., Penn State University
Patients
Healthy adults aged 21-70
Duration
6 months (randomized, double-blind, placebo-controlled)
Published in
European Journal of Clinical Nutrition
Year
2015
Key findings
GSH stores increased 30-35% over 6 months
Blood and cellular glutathione levels rose steadily over the treatment period, with significant increases measured at 1, 3, and 6 months. The increase was dose-dependent.
Oxidative stress markers decreased
8-OHdG (a marker of DNA oxidative damage) and 8-isoprostane (a marker of lipid oxidative damage) both decreased significantly, indicating real reduction in cellular damage.
Effects were sustained throughout treatment
Unlike some supplements that show initial spikes followed by adaptation, glutathione levels remained elevated throughout the 6-month period.
Well-tolerated with no significant adverse events
Glutathione supplementation showed a favorable safety profile across the entire study period, consistent with its status as an endogenous molecule.
What this means for you
This RCT confirmed that supplementing glutathione meaningfully increases the body's antioxidant reserves and reduces measurable oxidative damage. The 30-35% increase in GSH stores translates to better cellular protection against the oxidative stress caused by aging, poor sleep, exercise, and environmental toxins.
Limitations
The study used oral glutathione, which has lower bioavailability than injectable. This means injectable glutathione may produce even larger increases. The study measured biomarkers rather than clinical outcomes like infection rates or skin quality.
See if this compound is right for your goals
Take a 2-minute quiz. Get a personalized protocol.